Femoropopliteal Arterial Intervention

Part of the Medical Radiology book series (MEDRAD)


Since the publication of the TASC document in 2000 and the update of TASC II in 2007, several new devices have been developed which may improve the outcome of endovascular therapy in the SFA increasing the success rate and especially reducing the incidence of restenosis. Therefore the use of endovascular treatment in TASC A, B and C lesions may become the norm, especially with the new TASC IIB document, which is currently under review. This chapter will describe current techniques for SFA treatment of chronic lesions. The standard requisites needed will be named in a balanced manner especially with respect of implants such as stent and stent-grafts. In order to avoid implants and their potential limitations, this chapter will be completed by newer treatment concepts which cannot be stated as state-of-the art procedures like PTA and stent at the moment. Of these, DEBs might be one of the top treatment modalities in the future, if the early promising results are proved by the many on going trails. In general, interventional treatment of claudicants replaces more and more classical surgical techniques.


Stent Graft Superficial Femoral Artery Chronic Total Occlusion Restenosis Rate Stent Fracture 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Ahmadi R, Schillinger M, Maca T et al (2002) Femoropopliteal arteries: immediate and long-term results with a Dacron-covered stent-graft. Radiology 223:345–350PubMedCrossRefGoogle Scholar
  2. Amighi J, Schillinger M, Dick P, Schlager O, Sabeti S, Mlekusch W, Haumer M, Mathies R, Heinzle G, Schuster A, Loewe C, Koppensteiner R, Lammer J, Minar E, Cejna M (2008) De novo superficial femoropopliteal artery lesions: peripheral cutting balloon angioplasty and restenosis rates–randomized controlled trial. Radiology 247(1):267–272Google Scholar
  3. Ansel GM, Sample NS, Botti IC Jr et al (2004) Cutting balloon angioplasty of the popliteal and infrapopliteal vessels for symptomatic limb ischemia. Catheter Cardiovasc Interv 61:1–4PubMedCrossRefGoogle Scholar
  4. Bosiers M, Torsello G, Gissler HM, Ruef J, Müller-Hülsbeck S, Jahnke T, Peeters P, Daenens K, Lammer J, Schroë H, Mathias K, Koppensteiner R, Vermassen F, Scheinert D (2009) Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study. J Endovasc Ther 16(3):261–269PubMedCrossRefGoogle Scholar
  5. Böttcher HD, Schopohl B, Liermann D et al (1994) Endovascular irradiation—a new method to avoid recurrent stenosis after stent implantation in peripheral arteries: technique and preliminary results. Int J Radiat Oncol Biol Phys 29:183–186PubMedCrossRefGoogle Scholar
  6. Bray PJ, Robson WJ, Bray AE (2003) Percutaneous treatment of long superficial femoral artery occlusive disease: efficacy of the Hemobahn stent-graft. J Endovasc Ther 10:619–628PubMedCrossRefGoogle Scholar
  7. Cejna M (2005) Cutting balloon: review on principles and background of use in peripheral arteries. Cardiovasc Intervent Radiol 28:400–408PubMedCrossRefGoogle Scholar
  8. Cheng SW, Ting AC, Wong J (2001) Endovascular stenting of superficial femoral artery stenosis and occlusions: results and risk factor analysis. Cardiovasc Surg 9:133–140PubMedCrossRefGoogle Scholar
  9. Cotroneo AR, Pascali D, Iezzi R (2008) Cutting balloon versus conventional balloon angioplasty in short femoropopliteal arterial stenoses. J Endovasc Ther 15(3):283–291PubMedCrossRefGoogle Scholar
  10. Cotroneo AR, Iezzi R (2010) The role of “cutting” balloon angioplasty for the treatment of short femoral bifurcation steno-obstructive disease. Cardiovasc Intervent Radiol 33(5):921–928Google Scholar
  11. Desgranges P, Boufi M, Lapeyre M, Tarquini G, van Laere O, Losy F et al (2004) Subintimal angioplasty: feasible and durable. Eur J Vasc Endovasc Surg 28(2):138–141PubMedGoogle Scholar
  12. Deutschmann HA, Schedlbauer P, Berczi V et al (2001) Placement of Hemobahn stent-grafts in femoropopliteal arteries: early experience and midterm results in 18 patients. J Vasc Interv Radiol 12:943–950PubMedCrossRefGoogle Scholar
  13. Dick P, Sabeti S, Mlekusch W, Schlager O, Amighi J, Haumer M, Cejna M, Minar E, Schillinger M (2008) Conventional balloon angioplasty versus peripheral cutting balloon angioplasty for treatment of femoropopliteal artery in-stent restenosis: initial experience. Radiology 248(1):297–302PubMedCrossRefGoogle Scholar
  14. Dotter CT, Judkins MP (1964) Transluminal treatment of arteriosclerotic obstruction. Description of a new technic and a preliminary report of its application. Circulation 30:654–670PubMedCrossRefGoogle Scholar
  15. Duda SH, Bosiers M, Pusich B, Hüttl K, Oliva V, Müller-Hülsbeck S, Bray A, Lutz O, Remy C, Hak JB, Beregi JP (2002a) Endovascular treatment of peripheral artery disease with ePTFE covered nitinol stents—interim analysis from a prospective controlled study. Cardiovasc Intervent Radiol 4:413–418Google Scholar
  16. Duda SH, Pusich B, Richter G et al (2002b) Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation 106:1505–1509PubMedCrossRefGoogle Scholar
  17. Duda SH, Poerner TC, Wiesinger B et al (2003) Drug-eluting stents: potential applications for peripheral arterial occlusive disease. J Vasc Interv Radiol 14:291–301PubMedCrossRefGoogle Scholar
  18. Duda SH, Bosiers M, Lammer J et al (2005) Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol 16:331–338PubMedCrossRefGoogle Scholar
  19. Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Oliva V, Tielbeek A, Anderson J, Wiesinger B, Tepe G, Lansky A, Jaff MR, Mudde C, Tielemans H, Beregi JP (2006) Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther 13(6):701–710PubMedCrossRefGoogle Scholar
  20. Engelke C, Sandhu C, Morgan RA et al (2002) Using 6-mm Cutting Balloon angioplasty in patients with resistant peripheral artery stenosis: preliminary results. Am J Roentgenol 179:619–623Google Scholar
  21. Fava M, Loyola S, Polydorou A et al (2004) Cryoplasty for femoropopliteal arterial disease: late angiographic results of initial human experience. J Vasc Interv Radiol 15:1239–1243PubMedCrossRefGoogle Scholar
  22. Grassl ED, Bischof JC (2005) In vitro model systems for evaluation of smooth muscle cell response to cryoplasty. Cryobiology 50:162–173PubMedCrossRefGoogle Scholar
  23. Grenacher L, Saam T, Geier A, Müller-Hülsbeck S, Cenja M, Kauffmann GW, Richter GM (2004) PTA versus Stent bei Stenosen der A. femoralis und der A. poplitea: Ergebnisse einer prospektiv randomisierten Multizenterstudie (REFSA). Rofo- Fortschr Rontg 176:1302–1310CrossRefGoogle Scholar
  24. Grimm J, Müller-Hülsbeck S, Jahnke T, Hilbert C, Brossmann J, Heller M (2001) Randomized study to compare PTA alone versus PTA with Palmaz stenting for femoropopliteal lesions. J Vasc Interv Radiol 12:935–942PubMedCrossRefGoogle Scholar
  25. Jahnke T, Mueller-Huelsbeck S, Charalambous N, Trentmann J, Jamili A, Huemme TH, Bolte H, Heller M, Schaefer PJ (2010) Prospective, randomized single-center trial to compare cryoplasty versus conventional angioplasty in the popliteal artery: midterm results of the COLD study. J Vasc Interv Radiol 21(2):186–194PubMedCrossRefGoogle Scholar
  26. Krankenberg H, Schlüter M, Steinkamp HJ, Bürgelin K, Scheinert D, Schulte KL, Minar E, Peeters P, Bosiers M, Tepe G, Reimers B, Mahler F, Tübler T, Zeller T (2007) Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation 116(3):285–292Google Scholar
  27. Lammer J, Bosiers M, Zeller T, Schillinger M, Boone E, Zaugg MJ, Verta P, Peng L, Gao X, Schwartz LB (2011) First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease. J Vasc Surg 54(2):394–401Google Scholar
  28. Liermann D, Böttcher HD, Kollath J et al (1994) Prophylactic endovascular radiotherapy to prevent intimal hyperplasia after stent implantation in femoropopliteal arteries. Cardiovasc Intervent Radiol 17:12–16PubMedCrossRefGoogle Scholar
  29. Liermann DD, Bauernsachs R, Schopohl B et al (1997) Five year follow-up after brachytherapy for restenosis in peripheral arteries. Semin Interv Cardiol 2:133–137PubMedGoogle Scholar
  30. London N, Srinivasan R, Naylor A, Hartshorne T, Ratliff D, Bell P et al (1994) Subintimal angioplasty of femoropopliteal artery occlusions: the long-term results. Eur J Vasc Surg 8(2):148–155PubMedCrossRefGoogle Scholar
  31. McQuade K, Gable D, Pearl G, Theune B, Black S (2010) Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. J Vasc Surg 52(3):584–590PubMedCrossRefGoogle Scholar
  32. Mewissen MW (2004) Self-expanding nitinol stents in the femoropopliteal segment: technique and mid-term results. Tech Vasc Interv Radiol 7:2–5PubMedCrossRefGoogle Scholar
  33. Müller-Hülsbeck S, Link J, Steffens JC, Schwarzenberg H, Brossmann J, Hülsbeck A, Heller M (1997) MR imaging signal intensity abnormality after placement of arterial endoprotheses. Am J Roentgenol 169:743–748Google Scholar
  34. Müller-Hülsbeck S, Schäfer PJ, Charalambous N, Yagi H, Heller M, Jahnke T (2010) Comparison of second-generation stents for application in the superficial femoral artery: an in vitro evaluation focusing on stent design. J Endovasc Ther 17(6):767–776PubMedCrossRefGoogle Scholar
  35. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG et al (2007a) Inter-Society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg 33 (suppl 1):S1–S75, PMID 17140820Google Scholar
  36. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG et al (2007b) Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 45(suppl S):S5–S67, PMID 17223489Google Scholar
  37. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG et al (2007c) Inter-society consensus for the management of peripheral arterial disease. Int Angiol 26(2):81–157, PMID 17489079Google Scholar
  38. Pokrajac B, Pötter R, Maca T et al (2000) Intraarterial (192) Ir high-dose-rate brachytherapy for prophylaxis of restenosis after femoropopliteal percutaneous transluminal angioplasty: the prospective randomized Vienna-2-trial radiotherapy parameters and risk factors analysis. Int J Radiat Oncol Biol Phys 48:923–931PubMedCrossRefGoogle Scholar
  39. Pokrajac B, Potter R, Wolfram RM et al (2005) Endovascular brachytherapy prevents restenosis after femoropopliteal angioplasty: results of the Vienna-3 randomised multicenter study. Radiother Oncol 74:3–9PubMedCrossRefGoogle Scholar
  40. Pokrajac B, Kirisits C, Schmid R, Schillinger M, Berger D, Peer K, Tripuraneni P, Pötter R, Minar E (2009) Beta endovascular brachytherapy using CO2-filled centering catheter for treatment of recurrent superficial femoropopliteal artery disease. Cardiovasc Revasc Med 10(3):162–165Google Scholar
  41. Saxon RR, Coffman JM, Gooding JM et al (2003) Long-term results of ePTFE stent-graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial. J Vasc Interv Radiol 14:303–311PubMedCrossRefGoogle Scholar
  42. Sabeti S, Schillinger M, Amighi J, Sherif C, Mlekusch W, Ahmadi R, Minar E (2004) Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis. Radiology 232(2):516–521PubMedCrossRefGoogle Scholar
  43. Samson RH, Showalter DP, Lepore M Jr, Nair DG, Merigliano K (2008) CryoPlasty therapy of the superficial femoral and popliteal arteries: a reappraisal after 44 months’ experience. J Vasc Surg 48(3):634–637Google Scholar
  44. Scheinert D, Scheinert S, Sax J et al (2005) Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 45:312–315PubMedCrossRefGoogle Scholar
  45. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, Schlager O, Cejna M, Lammer J, Minar E (2006) Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 354(18):1879–1888PubMedCrossRefGoogle Scholar
  46. Schnorr B, Speck U, Scheller B (2011) Review of clinical data with paccocath-coated balloon catheters. Minerva Cardioangiol 59(5):431–445PubMedGoogle Scholar
  47. Schulte KL, Müller-Hülsbeck S, Cao P, Becquemin JP, Langhoff R, Charalambous N, Desgranges P, Kobeiter H, Midulla M, Vladimir Borovicanin V, Paunovic D, Beregi JP (2010) MISAGO 1:first-in-man clinical trial with Misago nitinol stent. EuroIntervention 5(6):687–691Google Scholar
  48. Suzuki K, Iida O, Soga Y, Hirano K, Inoue N, Uematsu M, Yokoi H, Muramatsu T, Nanto S, Nobuyoshi M, Meguro T (2011) Long-term results of the S.M.A.R.T. Control(TM) stent for superficial femoral artery lesions, J-SMART registry. Circ J 75(4):939–944Google Scholar
  49. Tepe G, Schmehl J, Claussen CD et al (2005) Drug coated stents for carotid intervention. J Cardiovasc Surg (Torino) 46:249–259Google Scholar
  50. Tepe G, Zeller T, Albrecht T, Heller S, Schwarzwälder U, Beregi JP, Claussen CD, Oldenburg A, Scheller B, Speck U (2008) Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med 358(7):689–699PubMedCrossRefGoogle Scholar
  51. Toutouzas K, Di Mario C, Falotico R et al (2002) Sirolimus-eluting stents: a review of experimental and clinical findings. Z Kardiol 91(Suppl 3):49–57PubMedCrossRefGoogle Scholar
  52. TransAtlantic Inter-Society Consensus (TASC) (2000) Management of peripheral arterial disease (PAD) Eur J Vasc Endovasc Surg 19 (Suppl A):Si-xxviii, S1-250:Si-250Google Scholar
  53. Vogel JH (1994) Stents: a time for clinical judgment. J Am Coll Cardiol 24:1213PubMedCrossRefGoogle Scholar
  54. Wolfram RM, Budinsky AC, Pokrajac B et al (2005a) Vascular brachytherapy with 192Ir after femoropopliteal stent implantation in high-risk patients: twelve-month follow-up results from the Vienna-5 trial. Radiology 236:343–351PubMedCrossRefGoogle Scholar
  55. Wolfram RM, Budinsky AC, Pokrajac B et al (2005b) Endovascular brachytherapy: restenosis in de novo versus recurrent lesions of femoropopliteal artery–the Vienna experience. Radiology 236:338–342PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg  2012

Authors and Affiliations

  1. 1.Department of Diagnostic and Interventional Radiology/NeuroradiologyEv.-Luth. Diakonissenanstalt zu Flensburg, Zentrum für Gesundheit und DiakonieFlensburgGermany

Personalised recommendations